Skip to main content
HALO filings

Corporate insider profile

Helen Torley Filing Activity

Latest reported as PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC. (HALO).

Purchase filings
0
Reported companies
1
Net open-market value
-$6,803,885.00
Latest transaction
Jun 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 3, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale50,000$67.40$3,370,010
May 13, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale50,000$68.68$3,433,875